We are live on ! Find out more
SGMT icon

Sagimet Biosciences
SGMT

81 hedge funds and large institutions have $122M invested in Sagimet Biosciences in 2024 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 31 increasing their positions, 11 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 5

182% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 11

61% more capital invested

Capital invested by funds: $76.2M → $122M (+$46.2M)

59% more funds holding

Funds holding: 51 → 81 (+30)

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

38.13% more ownership

Funds ownership: 67.62% → 105.75% (+38%)

Holders
81
Holders Change
+30
Holders Change %
+58.82%
% of All Funds
1.17%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
35
Increased
31
Reduced
11
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$19.2M
2
BlackRock
BlackRock
New York
+$11.8M
3
BOCH
Blue Owl Capital Holdings
New York
+$9.47M
4
JP Morgan Chase
JP Morgan Chase
New York
+$8.04M
5
RI
RTW Investments
New York
+$7.18M

Top Sellers

Rank Fund Capital Flow
1
NMC
NEA Management Company
Maryland
-$13.3M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$12.9M
3
HA
HHLR Advisors
Cayman Islands
-$5.2M
4
ACM
Altium Capital Management
New York
-$2.53M
5
AG
Artal Group
Luxembourg
-$1.44M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
26
Fidelity Investments
Massachusetts
$710K -$12.9M -1,791,060 -93%
BFM
27
Boothbay Fund Management
New York
$663K +$879K +122,365 New
N
28
Nuveen
North Carolina
$497K +$658K +91,655 New
PIM
29
Platinum Investment Management
Australia
$491K -$152K -21,119 -19%
Morgan Stanley
30
Morgan Stanley
New York
$440K +$412K +57,391 +241%
Two Sigma Investments
31
Two Sigma Investments
New York
$408K +$225K +31,321 +71%
UBS Group
32
UBS Group
Switzerland
$342K +$310K +43,148 +216%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$337K +$288K +40,056 +181%
EAM
34
Exome Asset Management
New York
$330K +$437K +60,900 New
XT
35
XTX Topco
Cayman Islands
$321K +$321K +44,682 +309%
YF
36
Yu Fan
$310K – – –
Federated Hermes
37
Federated Hermes
Pennsylvania
$293K -$311K -43,276 -44%
Victory Capital Management
38
Victory Capital Management
Texas
$282K -$33.3K -4,630 -8%
Charles Schwab
39
Charles Schwab
California
$281K +$282K +39,307 +313%
SO
40
STRS Ohio
Ohio
$281K +$341K +47,441 +1,054%
BCM
41
Bridgeway Capital Management
Texas
$244K – – –
Prudential Financial
42
Prudential Financial
New Jersey
$243K +$321K +44,755 New
LPL Financial
43
LPL Financial
California
$222K +$294K +41,000 New
Marshall Wace
44
Marshall Wace
United Kingdom
$193K +$136K +18,893 +113%
Acadian Asset Management
45
Acadian Asset Management
Massachusetts
$188K +$251K +34,929 New
Citadel Advisors
46
Citadel Advisors
Florida
$164K +$217K +30,266 New
Goldman Sachs
47
Goldman Sachs
New York
$161K +$214K +29,746 New
Susquehanna International Group
48
Susquehanna International Group
Pennsylvania
$151K +$201K +27,923 New
URS
49
Utah Retirement Systems
Utah
$141K +$187K +26,083 New
EGM
50
Engineers Gate Manager
New York
$137K +$182K +25,326 New
1
2
3 4

SGMT Hedge Fund Activity: Q1 2024 in Review

81 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Sagimet Biosciences (SGMT) for Q1 2024, worth a combined $122M — up 61% from $76.2M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new SGMT positions and 5 closed out — a net gain of 30 holders — while 31 added to existing stakes and 11 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $19.2M. The largest seller was NEA Management Company, cutting an estimated $13.3M.

  • 81 institutional investors held Sagimet Biosciences (SGMT) as of Q1 2024, up from 51 in Q4 2023.
  • Funds reported $122M of Sagimet Biosciences stock for Q1 2024, up 61% quarter-over-quarter.
  • 35 funds opened new Sagimet Biosciences positions in Q1 2024 and 5 closed out, a net change of +30 holders.
  • The largest Sagimet Biosciences buyer in Q1 2024 was Point72 Asset Management, an estimated $19.2M added.
  • The largest Sagimet Biosciences seller in Q1 2024 was NEA Management Company, an estimated $13.3M sold.

Based on aggregated 13F filings for Q1 2024.